ArticleVaccines2026

Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China.

Xueyang Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.